Home › NDC Lookup › RxCUI directory › RxCUI 404406

Montelukast 4 MG Oral Granules [Singulair] — RxCUI 404406

RxNorm drug concept · Semantic branded drug
RxCUI 404406 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI404406
Official nameMontelukast 4 MG Oral Granules [Singulair]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asSingulair 4 MG Oral Granules; Singulair 4 MG (montelukast sodium 4.2 MG) Oral Granules
FDA products mapped4
Package NDCs mapped5
Reported Medicaid activity (SDUD)562 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Montelukast: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It does more than just treat allergies. Montelukast is used to help prevent and control asthma on a daily basis, to prevent breathing problems triggered by exercise, and to relieve...
  • What is montelukast actually used for — is it just for allergies?
  • This is a real and important concern — the FDA has placed its strongest warning on montelukast because of reported mental health side effects. These can include mood changes, agita...
  • I heard montelukast can affect your mood. Should I be worried?
📖 Read our full Montelukast guide →

🕸️ Concept Web — How Montelukast 4 MG Oral Granules [Singulair] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Montelukast 4 MG Oral Granules [Singulair] RxCUI 404406

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Montelukast 88249
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Singulair 153889
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Montelukast Oral Granules 379540
    • Montelukast Granule Product 1295516
    • Montelukast Oral Product 1157311
    • Montelukast Oral Granules [Singulair] 406193
    • Singulair Granule Product 1296002
    • Singulair Oral Product 1183693
    • Oral Granules 317690
    • Granule Product 1294708
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Montelukast 4 MG Oral Granules SCD · 351246
  • Montelukast 4 MG SCDC · 330865
  • Montelukast Oral Granules SCDF · 379540
  • Montelukast Granule Product SCDG · 1295516
  • Montelukast Oral Product SCDG · 1157311

Brand-Name Concepts

  • Montelukast 4 MG [Singulair] SBDC · 542404
  • Montelukast Oral Granules [Singulair] SBDF · 406193
  • Singulair Granule Product SBDG · 1296002
  • Singulair Oral Product SBDG · 1183693
  • Singulair BN · 153889

📦 FDA Products & Package NDCs

4 products · 5 package NDCs
5 package NDCs map to RxCUI 404406 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
78206-0170-01 30 TABLET, CHEWABLE in 1 BOTTLE (78206-170-01) SINGULAIR Organon LLC 2021-06-01
78206-0171-01 30 PACKET in 1 CARTON (78206-171-01) / 1 GRANULE in 1 PACKE... SINGULAIR Organon LLC 2021-06-01
78206-0172-01 30 TABLET, FILM COATED in 1 BOTTLE (78206-172-01) SINGULAIR Organon LLC 2021-06-01
78206-0172-02 90 TABLET, FILM COATED in 1 BOTTLE (78206-172-02) SINGULAIR Organon LLC 2021-06-01
78206-0173-01 30 TABLET, CHEWABLE in 1 BOTTLE (78206-173-01) SINGULAIR Organon LLC 2021-06-01
Observed labelers: Organon LLC (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.